Amrize (NYSE:AMRZ) Downgraded by Wall Street Zen to “Sell”

Amrize (NYSE:AMRZ) was downgraded by Wall Street Zen from a “hold” rating to a “sell” rating in a research note issued on Saturday.

Other equities research analysts have also recently issued research reports about the stock. Royal Bank Of Canada increased their price target on shares of Amrize from $60.00 to $61.00 and gave the company a “sector perform” rating in a report on Thursday. Citigroup upped their price objective on Amrize from $63.00 to $67.00 and gave the company a “buy” rating in a research report on Thursday, January 8th. Oddo Bhf began coverage on Amrize in a report on Monday, November 3rd. They issued a “neutral” rating for the company. Deutsche Bank Aktiengesellschaft set a $59.00 price target on Amrize in a report on Monday, December 8th. Finally, Sanford C. Bernstein reaffirmed an “outperform” rating and set a $70.00 price objective on shares of Amrize in a research report on Thursday, December 18th. One analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating and six have issued a Hold rating to the company’s stock. According to data from MarketBeat, Amrize currently has a consensus rating of “Moderate Buy” and an average target price of $63.43.

Amrize Price Performance

Shares of NYSE:AMRZ opened at $65.06 on Friday. The business has a fifty day moving average price of $56.08 and a 200-day moving average price of $52.48. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.64 and a quick ratio of 0.97. The company has a market capitalization of $35.98 billion and a PE ratio of 35.36. Amrize has a 1-year low of $44.12 and a 1-year high of $65.26.

Amrize (NYSE:AMRZ) last announced its quarterly earnings results on Tuesday, February 17th. The company reported $0.62 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.59 by $0.03. The firm had revenue of $2.84 billion during the quarter, compared to the consensus estimate of $2.95 billion. The company’s revenue for the quarter was down .4% on a year-over-year basis.

Hedge Funds Weigh In On Amrize

A number of institutional investors and hedge funds have recently modified their holdings of AMRZ. Invesco Ltd. increased its position in Amrize by 27.2% during the fourth quarter. Invesco Ltd. now owns 571,266 shares of the company’s stock valued at $30,894,000 after acquiring an additional 122,027 shares during the last quarter. Alberta Investment Management Corp bought a new stake in shares of Amrize during the 4th quarter valued at about $13,039,000. Mercer Global Advisors Inc. ADV increased its position in shares of Amrize by 197.5% during the 4th quarter. Mercer Global Advisors Inc. ADV now owns 15,944 shares of the company’s stock valued at $862,000 after purchasing an additional 10,584 shares during the last quarter. Beacon Pointe Advisors LLC bought a new position in shares of Amrize in the 4th quarter worth approximately $935,000. Finally, Mackenzie Financial Corp lifted its stake in shares of Amrize by 26.6% in the 4th quarter. Mackenzie Financial Corp now owns 57,743 shares of the company’s stock worth $3,169,000 after purchasing an additional 12,146 shares during the period.

About Amrize

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.